IMVT IMMUNOVANT INC

Ownership history in Two Seas Capital LP  ·  12 quarters on record

This page tracks every 13F SEC filing in which Two Seas Capital LP reported a position in IMMUNOVANT INC (IMVT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.43% (2024 Q1)
Avg. % of fund
1.95%
First filed
2023 Q3
Last filed
2025 Q4
Quarters held
12
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 2,866,962 +104,922 +3.8% 1.50% $72.9M $25.42
2025 Q3 ADDED 2,762,040 +509,268 +22.6% 0.71% $44.5M $16.12
2025 Q2 ADDED 2,252,772 +610,000 +37.1% 0.61% $36.0M $16.00
2025 Q1 ADDED 1,642,772 +131,158 +8.7% 0.88% $28.1M $17.09
2024 Q4 ADDED 1,511,614 +835,000 +123.4% 3.24% $37.4M $24.77
2024 Q3 REDUCED 676,614 -15,792 -2.3% 3.12% $19.3M $28.51
2024 Q2 ADDED 692,406 +151,111 +27.9% 2.97% $18.3M $26.40
2024 Q1 ADDED 541,295 +454,695 +525.1% 3.43% $17.5M $32.31
2023 Q4 REDUCED 86,600 -112,152 -56.4% 0.89% $3.6M $42.13
2023 Q4 ADDED 198,752 +112,152 +129.5% 2.04% $8.4M $42.13
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    IMVT price (monthly, adj. close)
← Back to Two Seas Capital LP Holdings